Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Published:2013-01 Issue:9863 Volume:381 Page:295-302
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Demetri George D,Reichardt Peter,Kang Yoon-Koo,Blay Jean-Yves,Rutkowski Piotr,Gelderblom Hans,Hohenberger Peter,Leahy Michael,von Mehren Margaret,Joensuu Heikki,Badalamenti Giuseppe,Blackstein Martin,Le Cesne Axel,Schöffski Patrick,Maki Robert G,Bauer Sebastian,Nguyen Binh Bui,Xu Jianming,Nishida Toshirou,Chung John,Kappeler Christian,Kuss Iris,Laurent Dirk,Casali Paolo G

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors;Demetri;J Natl Compr Canc Netw,2010

2. Adjuvant treatment of GIST: patient selection and treatment strategies;Joensuu;Nat Rev Clin Oncol,2012

3. Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas;Edmonson;Cancer Invest,2002

4. Clinical management of gastrointestinal stromal tumors: before and after STI-571;Dematteo;Hum Pathol,2002

5. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options;Caram;J Surg Oncol,2011

Cited by 1153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor;Cancer Letters;2024-10

2. Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST;Experimental and Molecular Pathology;2024-10

3. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy;Current Treatment Options in Oncology;2024-09-11

4. Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance;Cancers;2024-09-07

5. Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin;Frontiers in Oncology;2024-09-03